|
SIGNIFICANT ACCOUNTING POLICIES (Details Textual) (USD $)
|
1 Months Ended | 12 Months Ended | |
|---|---|---|---|
|
Jul. 23, 2014
|
Dec. 31, 2014
|
Dec. 31, 2013
|
|
| Concentration Risk, Percentage | 3.00%us-gaap_ConcentrationRiskPercentage1 | 5.00%us-gaap_ConcentrationRiskPercentage1 | |
| Advertising Expense | $ 103,624us-gaap_AdvertisingExpense | $ 61,536us-gaap_AdvertisingExpense | |
| Research and Development Expense | 531,676us-gaap_ResearchAndDevelopmentExpense | 386,109us-gaap_ResearchAndDevelopmentExpense | |
| Effective Income Tax Rate Reconciliation, Deduction, Other, Percent | 50.00%us-gaap_EffectiveIncomeTaxRateReconciliationDeductionsOther | ||
| Accrued Initial Public Offering Costs | 0mtbc_AccruedInitialPublicOfferingCosts | 430,125mtbc_AccruedInitialPublicOfferingCosts | |
| Foreign Currency Transaction Gain (Loss), before Tax | (122,163)us-gaap_ForeignCurrencyTransactionGainLossBeforeTax | 199,919us-gaap_ForeignCurrencyTransactionGainLossBeforeTax | |
| IPO [Member] | |||
| Initial Public Offering Costs |
1,170,582mtbc_InitialPublicOfferingCosts / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
1,312,850mtbc_InitialPublicOfferingCosts / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
|
| Accrued Initial Public Offering Costs |
430,125mtbc_AccruedInitialPublicOfferingCosts / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
||
| Stock Issued During Period, Shares, New Issues |
4,080,000us-gaap_StockIssuedDuringPeriodSharesNewIssues / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
||
| Share Price |
$ 5.00us-gaap_SharePrice / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
||
| Proceeds from Issuance Initial Public Offering |
16,300,000us-gaap_ProceedsFromIssuanceInitialPublicOffering / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
||
| Adjustments to Additional Paid in Capital, Other |
2,483,432us-gaap_AdjustmentsToAdditionalPaidInCapitalOther / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
||
| Business Combination, Acquisition Related Costs |
$ 862,886us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
$ 281,048us-gaap_BusinessCombinationAcquisitionRelatedCosts / us-gaap_SubsidiarySaleOfStockAxis = us-gaap_IPOMember |
|
| Computer Equipment [Member] | |||
| Property, Plant and Equipment, Estimated Useful Lives | three | ||
| Other Assets [Member] | |||
| Property, Plant and Equipment, Estimated Useful Lives | five | ||
| Maximum [Member] | |||
| Property, Plant and Equipment, Estimated Useful Lives | five | ||
| Minimum [Member] | |||
| Property, Plant and Equipment, Estimated Useful Lives | three | ||
| Acquired Entities [Member] | |||
| Concentration Risk, Percentage |
36.00%us-gaap_ConcentrationRiskPercentage1 / dei_LegalEntityAxis = mtbc_AcquiredEntitiesMember |
||
| Customer Concentration Risk [Member] | |||
| Concentration Risk, Percentage |
64.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember |
90.00%us-gaap_ConcentrationRiskPercentage1 / us-gaap_ConcentrationRiskByTypeAxis = us-gaap_CustomerConcentrationRiskMember |
|
| X | ||||||||||
|
- Definition
Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from initial public offering. No definition available.
|
| X | ||||||||||
|
- Definition
Represents Total initial public offering costs incurred during the period. Such as professional fees, primarily legal and accounting, and printing and registration costs. No definition available.
|
| X | ||||||||||
|
- Definition
Amount of other increase (decrease) in additional paid in capital (APIC). No definition available.
|
| X | ||||||||||
|
- Definition
Amount charged to advertising expense for the period, which are expenses incurred with the objective of increasing revenue for a specified brand, product or product line. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
This element represents acquisition-related costs incurred to effect a business combination which costs have been expensed during the period. Such costs include finder's fees; advisory, legal, accounting, valuation, and other professional or consulting fees; general administrative costs, including the costs of maintaining an internal acquisitions department; and may include costs of registering and issuing debt and equity securities. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Percentage of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to other deductions. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Amount before tax of foreign currency transaction realized and unrealized gain (loss) recognized in the income statement. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The cash inflow associated with the amount received from entity's first offering of stock to the public. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Describes the periods of time over which an entity anticipates to receive utility from its property, plant and equipment (that is, the periods of time over which an entity allocates the initial cost of its property, plant and equipment). Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
The aggregate costs incurred (1) in a planned search or critical investigation aimed at discovery of new knowledge with the hope that such knowledge will be useful in developing a new product or service, a new process or technique, or in bringing about a significant improvement to an existing product or process; or (2) to translate research findings or other knowledge into a plan or design for a new product or process or for a significant improvement to an existing product or process whether intended for sale or the entity's use, during the reporting period charged to research and development projects, including the costs of developing computer software up to the point in time of achieving technological feasibility, and costs allocated in accounting for a business combination to in-process projects deemed to have no alternative future use. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Definition
Price of a single share of a number of saleable stocks of a company. No definition available.
|
| X | ||||||||||
|
- Definition
Number of new stock issued during the period. Reference 1: http://www.xbrl.org/2003/role/presentationRef
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|
| X | ||||||||||
|
- Details
|